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INTRODUCTION:  Clear  cell  sarcoma  (CCS)  is  a  rare  tumour  of the  soft  tissue  often  misdiagnosed,  as it  shares
characteristics  with  malignant  melanoma  (MM).  Previously,  CCS  has  been  characterised,  as  malignant
melanoma  of the  soft  tissue,  contemporary  immunohistochemical  techniques,  however,  have  made  this
designation obsolete.  The  true  incidence  remains  unknown,  but  CCS  is  believed  to  represent  less than
one  percent  of all sarcomas.
PRESENTATION  OF  CASE:  A 22-year-old  patient  presented  with  a  mass  sized  2.6  ×  2.7  ×  2.7 cm  of  the left
gluteal  region,  pain,  and  malaise.  Initially,  the symptoms  were  interpreted  as  an  infection.  Subsequent,
pathological  diagnosis  after  surgical  removal  was  tentatively  MM  albeit  deﬁnitive  pathological  diagnosis
was  CCS.
DISCUSSION:  The  patient  of this  case  underwent  deﬁnitive  surgical  treatment  with  2  cm  margin.  In  spite
of  time  delay,  because  of  prolonged  time  for deﬁnitive  diagnosis,  PET-CT  and  sentinel  lymph  node  biopsy
did  not  show  any  metastasis.  One-year  postoperatively,  multidisciplinary  follow-up  is  without  suspicion
of  relapse.
CONCLUSION:  Accurate  and  timely  diagnosis  of  CCS  are  imperative,  as  initial  misdiagnosis,  may  cause
delay  and  further  tumour  growth,  which  is  correlated  to the prognosis.
© 2017  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Clear cell sarcoma of tendons and aponeuroses or soft tissue
or simply just clear cell sarcoma (CCS) are tumours of very low
incidence derived from neural crest cells originating from the soft
tissue, representing an estimated one percent of all sarcomas, yet,
the true incidence remains unknown [1,2]. In 2013 the annual inci-
dence of all sarcomas of the soft tissue were 220 in Denmark [3].
Hitherto, no descriptions of CCS from Denmark are available in the
English literature, and only three occurrences of CCS are reported
in Denmark in the period from 2009 to 2013 [3]. This case is dis-
seminated according to the SCARE criteria [4]. The treatment of this
patient was managed at a university hospital in Denmark.
CCS shares morphological similarities with malignant
melanoma (MM),  hence, the key process in the diagnosis of
CCS is to distinguish it from other tumours, i.e. MM in particular,
to facilitate fast, correct, and appropriate treatment [5,6]. The neo-
plastic cells of CCS are clear or pale, appear polygonal to fusiform
with eosinophilic to amphophilic cytoplasm, and have centrally
located uniform and round nuclei with prominent basophilic
nucleoli, similar to that of MM [5]. The clear cell appearance is due
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to the accumulation of glycogen (Fig. 1). CCS was previously char-
acterised as MM of the soft tissue, but contemporary techniques
have made this designation obsolete [5]. Debut is on average dur-
ing the third decade, the male-female ratio is approximately 1:1,
although CCS seems to be slightly more common in females. The
lower limbs are most frequently affected [5]. The most common
presentation is a slowly growing and tender or painful lump of
the extremities. As the tumour grows, it invades nearby tissues
and over time, symptoms of more advanced cancer might develop,
including i.a. weight loss, malaise and loss of appetite. The 5-year
survival is estimated to 63 percent and tumour size is implicated
in the prognosis [7,8].
2. Presentation of case
A 22-year-old university student with no previous medical his-
tory presented to the Accident and Emergency Department after
referral from her General Practitioner with a growing mass of
the left gluteal region. The patient had experienced local tender-
ness and malaise for approximately one week prior to contact.
No previous trauma was present and the patient was not on any
medication. There was  no family history of any cancers and the
patient did not smoke. An ultrasound showed a well-delimited
mass of 2.6 × 2.7 × 2.7 cm below skin, but above the gluteal mus-
cles (Fig. 2). Initially, the process was suspected to represent an
infection. Hence, an operation was made to evacuate the potential
http://dx.doi.org/10.1016/j.ijscr.2017.05.034
2210-2612/© 2017 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Periodic acid-Schiff stain. Clear cell sarcoma. Clear cell appearance because of glycogen accumulation in cytoplasm.
Fig. 2. Preoperative ultrasonography of the patient’s gluteal region.
abscess. During the operation a centrally located solid mass was
noted, which the surgeon removed in toto. Subsequent pathological
diagnosis was MM and the patient was referred to the Department
of Plastic Surgery for further treatment. An interim PET-CT revealed
no metastases. At the Department of Plastic Surgery, in general
anaesthesia the patient had further surgery to remove any remain-
ing tumour and to make sentinel lymph node biopsy. The surgeon
was a Consultant Plastic Surgeon. The lymph node biopsy revealed
no tumour cells. A pathological revision of the tumour concluded
that the tumour represented CCS with intact surgical margins of
two cm.  For follow-up, the patient has been referred to a multidis-
ciplinary sarcoma centre. Included in the follow-up are chest x-rays
and PET-CTs. One-year postoperatively, the patient adheres to the
follow-up programme without any signs of relapse.
3. Discussion
The present case of CCS represents an unfortunately typical
course of CCS, as the tumour was  misdiagnosed initially (Fig. 3a
and b). In this case a 22-year-old lady presented with localised
pain, an expanding mass, and lethargy. In previous cases of CCS
manifestations resembling the current case were evident [1,2,7].
Mean age and localisation of tumour are parallel to the present
case, as the lower limbs seem to be most frequently affected [9]. In a
retrospective study of patients with CCS, the tumours occurred pre-
dominantly in young patients between the age of 15 and 35 years
[9], Furthermore, females were slightly more affected than male
patients [9]. The current case is therefore a common presentation
of CSS and in spite of this, the diagnosis was  not made primarily,
which further underlines the importance to consider both CCS and
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Fig. 3. (a) Typical appearance of clear cell sarcoma on MRI  enhanced by contrast
administration. b Typical appearance of clear cell sarcoma on MRI  without contrast
administration.
MM in cases of doubt to ensure timely and correct diagnosis for
optimal treatment. Fortunately in the present case, the tumour size
remained within the reach of surgery despite delay and the patient
remains cancer free.
The treatment protocols of both CCS and MM was followed in the
current case, as MM of this size should be surgically removed with a
margin of two cm [10]. No current national guideline for CCS exists,
however, a surgical margin of at least one cm is accepted domesti-
cally [3]. Follow-up differs, as chemotherapy may  be beneﬁcial in
selected cases of MM,  whereas CCS does not seem to respond to
neither chemotherapy nor radiation [11,12]. In all cases a multidis-
ciplinary approach for follow-up is recommended.
Regarding pathological examination, no common signs or symp-
toms, atypically localisation, and/or presentation of MM should
warrant further examinations, if the histological features of the
tumour presents as typically to MM,  considering CCS as main differ-
ential diagnosis [7]. Keep in mind that approximately two thirds of
all CCS contain melanin, and therefore are S-100 positive, whereas
the immunological proﬁle for CCS is typically positive for melan-
A, HMB-45, and microphthalmia transcription factor [7]. In 90% of
all cases of CCS polymerase chain reaction and ﬂuorescence in situ
hybridisation can detach the translocation (t[12; 22] [q13;q12]) or
a resultant EWSR1-ATF1 fusion gene unique for CCS [7,13].
4. Conclusion
Although, CCS is a rare tumour, it should be kept in mind in cases
of patients presenting with tumours of the soft tissue. Furthermore,
an initial diagnosis of MM in tumours of the soft tissue should war-
rant further examinations to exclude CCS, for the optimal speciﬁc
treatment, albeit all delays should be diminished if possible, as
more time spend on diagnosis potentially equals a larger tumour
and a more sinister prognosis.
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